PTHL: Gunggung utang perusahaan Pheton

Pheton Holdings Ltd possesses significant pricing power driven by its AI systems for precision brachytherapy planning. The total debt burden reflects creditor pressure, where this metric equals 0.00. Stable demand is sustained by the supply of radiotherapy equipment to clinics across China. The medical community's professional interest in the brand's developments confirms its growing reputation within the biotech sector.

Investors must evaluate the stability of Pheton Holdings Ltd (PTHL) by analyzing the aggregate of credit obligations and bond loans. This aggregate debt chart demonstrates the balance between financial leverage and default risk, which is critical for a company whose operations are exposed to geopolitical risks in Asian raw material supply chains and the complexities of international software licensing.